Back to mobile site

BMO Capital Downgrades MacroGenics (MGNX) to Market Perform

May 10, 2024 3:35 AM EDT Send to a Friend
(Updated - May 10, 2024 4:59 AM EDT)

BMO Capital analyst Etzer Darout downgraded MacroGenics (NASDAQ: MGNX) from Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login